Concourse Financial Group Securities, Inc. Cyclacel Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change
Q3 2024 Oct 10, 2024	BUY	N/A	0 New
Q2 2024 Jul 23, 2024	BUY	N/A	0 New
Q1 2024 Apr 30, 2024	BUY	N/A	0 New
Q4 2023 Feb 07, 2024	BUY	N/A	0 New
Q3 2023 Oct 30, 2023	BUY	N/A	0 New
Q3 2023 Oct 25, 2023	BUY	N/A	0 New
Q2 2023 Aug 10, 2023	BUY	N/A	0 New
Q1 2023 May 15, 2023	BUY	N/A	0 New
Q4 2022 Jan 30, 2023	BUY	N/A	0 New
Q3 2022 Nov 15, 2022	BUY	N/A	0 New
Q2 2022 Aug 09, 2022	BUY	N/A	0 New
Q1 2022 May 09, 2022	BUY	N/A	0 New
Q4 2021 Feb 07, 2022	BUY	N/A	0 New
Q2 2020 Aug 13, 2020	SELL	N/A	0 Closed
Q1 2020 May 13, 2020	BUY	N/A	0 New
Q4 2019 Feb 14, 2020	BUY	N/A	0 New
Q3 2019 Nov 13, 2019	BUY	N/A	0 New
Q2 2019 Aug 13, 2019	BUY	N/A	0 New
Q1 2019 May 15, 2019	BUY	N/A	0 New
Q4 2018 Feb 14, 2019	BUY	N/A	0 New
Q3 2018 Nov 13, 2018	BUY	N/A	0 New

Others Institutions Holding CYCCP

# of Institutions

Shares Held

Call Options Held

Put Options Held

Sound Income Strategies, LLC

94
Shares

$0
0.0% of portfolio

View Full List

About Cyclacel Pharmaceuticals, Inc.

Ticker CYCCP
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,497,400
Market Cap $16.5M

More about CYCCP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account